541 related articles for article (PubMed ID: 33487481)
1. Membranous Nephropathy: Core Curriculum 2021.
Alsharhan L; Beck LH
Am J Kidney Dis; 2021 Mar; 77(3):440-453. PubMed ID: 33487481
[TBL] [Abstract][Full Text] [Related]
2. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
3. A Target Antigen-Based Approach to the Classification of Membranous Nephropathy.
Bobart SA; Tehranian S; Sethi S; Alexander MP; Nasr SH; Moura Marta C; Vrana JA; Said S; Giesen CD; Lieske JC; Fervenza FC; De Vriese AS
Mayo Clin Proc; 2021 Mar; 96(3):577-591. PubMed ID: 33673911
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Primary Membranous Nephropathy.
Gu Y; Xu H; Tang D
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
[TBL] [Abstract][Full Text] [Related]
5. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
6. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan.
Iwakura T; Ema C; Isobe S; Fujikura T; Ohashi N; Kato A; Yasuda H
Sci Rep; 2022 Feb; 12(1):2967. PubMed ID: 35194125
[TBL] [Abstract][Full Text] [Related]
8. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Safar-Boueri L; Piya A; Beck LH; Ayalon R
Pediatr Nephrol; 2021 Jan; 36(1):19-30. PubMed ID: 31811540
[TBL] [Abstract][Full Text] [Related]
11. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
12. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
[TBL] [Abstract][Full Text] [Related]
13. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
[TBL] [Abstract][Full Text] [Related]
14. New Ways of Understanding Membranous Nephropathy.
Trujillo H; Alonso M; Praga M
Nephron; 2020; 144(6):261-271. PubMed ID: 32229730
[TBL] [Abstract][Full Text] [Related]
15. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence?
Chen R; Wang J; Xie Q; Xue J; Hao C
Int J Rheum Dis; 2021 Aug; 24(8):1086-1094. PubMed ID: 34223708
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
18. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
20. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
